A Ukrainian fitness influencer has apologised after a disturbing video of him sitting on a turtle and holding its babies circulated online.
READ MOREThe man was reportedly pulled from the water on Kato Gouves beach unconscious (Picture: Shutterstock / Peter Etchells)
The skeletons were discovered on the island of Sulawesi (Picture: Science Advance) Scientists believe they have found the earliest known human use of psychoactive drugs among foragers who lived 25,00
JARKATA,Indonesia,Feb. 14,2025--The ASEAN Foundation,supported by Google.org,successfully hosted the 1st Regional Policy Convening of AI Ready ASEAN at ASEAN Headquarters/ASEAN Secretariat,Jakarta,on
GUANGZHOU,China,Feb. 14,2025-- News report from GDToday. A photo exhibition titled "Nihao,China! See You in Guangdong" was held in Orange County,California,from January 23 to February 12,sho
HANGZHOU,China,Feb. 14,2025-- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK),the world\'s leading premium new energy vehicle group,today a
WUHU,China,Feb. 14,2025--The T1 series,a new member ofJETOUR brand with a lite off-road shape artfully blending sportiness and toughness,has been awarded the 2024 Red Dot Design Concept Award. By winn
SINGAPORE,Feb. 14,2025-- ATxEnterprise (ATxE) 2025,a flagship event of Asia Tech x Singapore (ATxSG),returns for its fifth year,providing a strategic platform for enterprises,governments,and technolo
BEIJING,Feb. 14,2025--A news report by China.org.cn on China\'s AI application:  
SHENZHEN,China,Feb. 14,2025-- Kexing Biopharm Co.,Ltd. (Stock Code: 688136.SH) recently announced that the Investigational New Drug Application (IND) of GB05,Human Interferon α1b Inhalation Solution,
SEOUL,South Korea,Feb. 13,2025-- DAAN Biotherapeutics,a leading innovative drug development company specializing in T-cell receptor (TCR)- based therapies,has signed an exclusive licensing agreement w
SINGAPORE,Feb. 13,2025-- Mega Matrix Inc. (NYSE American: MPU)\'s globally leading short series streaming platform,FlexTV,has launched a romantic miniseries exploring love,responsibility,and redempti
XPOVIO® is the first XPO1 inhibitor approved in Taiwan for the treatment of adult patients with relapsed/refractory multiple myeloma (R/R MM).
© OfficialAffairs
